NCT02318511已完成不适用
An Investigation of ReNu™ Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 22
- 主要终点
- VAS Pain Scale Change from Baseline
研究概览
简要总结
This is a Prospective, Randomized study evaluating the efficacy of ReNu for the treatment of Kellgren-Lawrence grade 2 or 3 osteoarthritis. Patients will be randomized into 1 of 3 groups for injection into the effected knee: 1) ReNu - study treatment, 2) Hyaluronic Acid (HA) injection - with commonly used injection material and 3) Saline. After treatment, patients will be followed up to 12 months to evaluate improvements using common pain and function subscales.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients with moderate knee osteoarthritis determined by a combination of clinical and radiographic findings and documented by Kellgren-Lawrence radiographic classification (Grade 2 or 3)
- •Grade 2 Kellgren-Lawrence radiographic changes are defined as small osteophytes, possible narrowing of joint space
- •Grade 3 Kellgren-Lawrence radiographic changes are defined as moderate multiple osteophytes, definite narrowing of joints space, some sclerosis and possible deformity of bone contour.
- •Patients with bilateral grade 2 or 3 Kellgren Lawrence knee osteoarthritis who have bilateral symptoms may have their more symptomatic knee injected. If equivalent symptoms are reported by the patient, then the patient will choose which knee is to be injected. The contralateral knee can be treated with local standard of care such as steroid injection, cold therapy or soft brace.
- •Age 18 and older
- •BMI less than 40
- •7 day average pain score of 4 or greater for the involved knee on a numeric pain scale from 1 to
- •Female patients must be actively practicing a contraception method, abstinence, be surgically sterilized, or be postmenopausal
排除标准
- •Pain medication (including nonsteroidal antiinflammatory drugs, NSAIDs) less than 15 days before injection (may take acetaminophen)
- •Receiving pain medication other than acetaminophen for conditions unrelated to osteoarthritis of the index knee
- •Regular use of anticoagulants, such as Coumadin, dabigatran or rivaroxaban; use of antiplatelet medications are not a reason for exclusion
- •History of substance abuse.
- •Failure to agree NOT to take additional knee symptom modifying drugs, other than acetaminophen, during the course of the study without reporting to the study team
- •Pregnancy or desire to become pregnant during study duration
- •Positive pregnancy test on premenopausal subject
- •Morbid obesity (defined as BMI 40 or greater)
- •Symptoms of locking, intermittent block to range of motion or loose body sensation which could indicate meniscal displacement or an intraarticular loose body
- •Corticosteroid injection into the index knee within 3 months
- •Viscosupplement injection into the index knee within 3 months
- •Knee surgery of involved index knee within 12 months
- •Knee surgery contralateral knee 6 months
- •Worker compensation
- •Acute index knee injury (injury within 3 months)
- •History of Diabetes mellitus
- •History of solid organ or hematologic transplantation
- •History of rheumatoid arthritis or other autoimmune disorder
- •Diagnosis of a non-basal cell malignancy within the preceding 5 years
- •Infection requiring antibiotic treatment within the preceding 3 months
- •Current therapy with any immunosuppressive medication, including corticosteroids at a dose > 5 mg per day
结局指标
主要结局
VAS Pain Scale Change from Baseline
时间窗: 6 months
KOOS Pain and Function Subscales Change from Baseline
时间窗: 6 months
次要结局
- KOOS Pain and Function Subscales change from Baseline(1 week, 6 weeks, 3 months, and 12 months)
- Other patient reported outcomes (PROs) change from Baseline(1 week, 6 week, 3 months, 6 months, and 12 months)
- Radiographic (X-ray) measurement of standing joint space change from Baseline(12 months)
研究者
研究点 (22)
Loading locations...
相似试验
Unknown
不适用
Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty PatientsFlexion ContractureNCT02638480Anne Arundel Health System Research Institute100
已完成
不适用
Clinical Outcomes of Increased Flexion Total Knee Replacement.Osteoarthritis of the kneeMusculoskeletal - OsteoarthritisACTRN12606000325505Mater Health Services40
已完成
不适用
A randomized controlled trial for improving knee joint pain in humaHealthy adultsJPRN-UMIN000014324ORTHOMEDICO Inc.96
招募中
不适用
Prospective follow-up of clinical efficacy of knee distraction as treatment for knee OA by use of 'ArthroSave's Knee-Reviver'.10005944knee osteoarthritisNL-OMON55548niversitair Medisch Centrum Utrecht70
招募中
不适用
Prospective follow-up of clinical efficacy of knee distraction as treatment for knee osteoarthritis by use of ‘ArthroSave’s Knee-Reviver’Knee osteoarthritisNL-OMON25021MC Utrecht75